Latest filing published 09 Mar 2021 for Apollo Endosurgery, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sciences Ii L. P. Ptv: trading record in brief
Sciences Ii L. P. Ptv has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Apollo Endosurgery, Inc., LDR Holding Corp and Intersect ENT, Inc. We count 33 filings; the first trade dates from 15 October 2013 and the latest from 24 February 2021.
The open-market record is one-sided, with 5 purchases worth €6.3M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €277k and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 9 March 2021 with a transaction in Apollo Endosurgery, Inc. The most recent open-market purchase was published on 25 September 2017, 3,332 days ago. Filings reach the SEC (Form 4) feed a median of 13 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sciences Ii L. P. Ptv
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 857,964 sharesCommon StockSEC:0001104659-21-033846:0
- 857,964 sharesCommon StockSEC:0001104659-21-033846:1
- 857,964 sharesCommon StockSEC:0001104659-21-033846:2
- 1,347,565 sharesCommon StockSEC:0001104659-21-033846:3
- 13,473 sharesCommon StockSEC:0001104659-21-033846:4
- 13,473 sharesCommon StockSEC:0001104659-21-033846:5
- 605,712 sharesCommon StockSEC:0001104659-21-033846:6
- 6,055 sharesCommon StockSEC:0001104659-21-033846:7
- 6,055 sharesCommon StockSEC:0001104659-21-033846:8
- 1,341,222 sharesCommon StockSEC:0000899243-20-016954:0
- 245,444 sharesCommon StockSEC:0000899243-20-016954:1
- 245,444 sharesCommon StockSEC:0000899243-20-016954:2
- 1,266,909 sharesCommon StockSEC:0000899243-17-027685:0
- 12,669 sharesCommon StockSEC:0000899243-17-027685:1
- 12,669 sharesCommon StockSEC:0000899243-17-027685:2
- 41,000 shares@ US$4.042.4% of flowCommon StockSEC:0000899243-17-022528:0Canonical exit: 4 Dec 2017 (T+90)
- 135,000 shares@ US$3.857.6% of flowCommon StockSEC:0000899243-17-022528:1Canonical exit: 11 Dec 2017 (T+90)
- 1,090,909 shares@ US$5.5090.0% of flowCommon StockSEC:0001179110-17-010723:0Canonical exit: 23 Oct 2017 (T+90)
- 1,347,565 sharesCommon StockSEC:0001179110-16-033599:0
- 2,199,186 sharesCommon StockSEC:0001179110-16-033599:1
- 605,712 sharesCommon StockSEC:0001179110-16-033599:2
- 644,242 shares0Common StockSEC:0001209191-15-005240:0
- 974,025 sharesCommon StockSEC:0001209191-14-049403:0
- 1,198,630 sharesCommon StockSEC:0001209191-14-049403:1
- 404,311 sharesCommon StockSEC:0001209191-14-049403:2
25 of 32 declarations